[Reactivation in immunosuppression. Complicated hepatitis comeback].
D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000517:prevention & control; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000209:etiology* / Q000517:prevention & control; D006526:Hepatitis C / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000209:etiology* / Q000517:prevention & control; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control; D014775:Virus Activation / Q000187:drug effects*; D017735:Virus Latency / Q000187:drug effects
D007166:Immunosuppressive Agents